Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study

DOI record: { "DOI": "10.1007/s40121-020-00363-w", "ISSN": [ "2193-8229", "2193-6382" ], "URL": "http://dx.doi.org/10.1007/s40121-020-00363-w", "alternative-id": [ "363" ], "assertion": [ { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Received", "name": "received", "order": 1, "value": "17 September 2020" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "Accepted", "name": "accepted", "order": 2, "value": "19 October 2020" }, { "group": { "label": "Article History", "name": "ArticleHistory" }, "label": "First Online", "name": "first_online", "order": 3, "value": "2 November 2020" } ], "author": [ { "ORCID": "http://orcid.org/0000-0003-2459-1485", "affiliation": [], "authenticated-orcid": false, "family": "Abu Esba", "given": "Laila Carolina", "sequence": "first" }, { "affiliation": [], "family": "Alqahtani", "given": "Rahaf Ali", "sequence": "additional" }, { "affiliation": [], "family": "Thomas", "given": "Abin", "sequence": "additional" }, { "affiliation": [], "family": "Shamas", "given": "Nour", "sequence": "additional" }, { "affiliation": [], "family": "Alswaidan", "given": "Lolowa", "sequence": "additional" }, { "affiliation": [], "family": "Mardawi", "given": "Gahdah", "sequence": "additional" } ], "container-title": "Infectious Diseases and Therapy", "container-title-short": "Infect Dis Ther", "content-domain": { "crossmark-restriction": false, "domain": [ "link.springer.com" ] }, "created": { "date-parts": [ [ 2020, 11, 2 ] ], "date-time": "2020-11-02T04:18:16Z", "timestamp": 1604290696000 }, "deposited": { "date-parts": [ [ 2021, 3, 12 ] ], "date-time": "2021-03-12T06:39:11Z", "timestamp": 1615531151000 }, "indexed": { "date-parts": [ [ 2022, 8, 6 ] ], "date-time": "2022-08-06T13:52:16Z", "timestamp": 1659793936156 }, "is-referenced-by-count": 31, "issue": "1", "issued": { "date-parts": [ [ 2020, 11, 2 ] ] }, "journal-issue": { "issue": "1", "published-print": { "date-parts": [ [ 2021, 3 ] ] } }, "language": "en", "license": [ { "URL": "https://creativecommons.org/licenses/by-nc/4.0", "content-version": "tdm", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 11, 2 ] ], "date-time": "2020-11-02T00:00:00Z", "timestamp": 1604275200000 } }, { "URL": "https://creativecommons.org/licenses/by-nc/4.0", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2020, 11, 2 ] ], "date-time": "2020-11-02T00:00:00Z", "timestamp": 1604275200000 } } ], "link": [ { "URL": "http://link.springer.com/content/pdf/10.1007/s40121-020-00363-w.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "http://link.springer.com/article/10.1007/s40121-020-00363-w/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining" }, { "URL": "http://link.springer.com/content/pdf/10.1007/s40121-020-00363-w.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "297", "original-title": [], "page": "253-268", "prefix": "10.1007", "published": { "date-parts": [ [ 2020, 11, 2 ] ] }, "published-online": { "date-parts": [ [ 2020, 11, 2 ] ] }, "published-print": { "date-parts": [ [ 2021, 3 ] ] }, "publisher": "Springer Science and Business Media LLC", "reference": [ { "key": "363_CR1", "unstructured": "Times P. Managing and Treating Fever: A Guide to Nonprescription Antipyretics 2018. https://www.pharmacytimes.com/publications/issue/2018/February2018/managing-and-treating-fever-a-guide-to-nonprescription-antipyretics. Accessed 19 March 2020." }, { "key": "363_CR2", "unstructured": "Chandler M. Global ibuprofen shortage hits UK supermarkets—with shelves left empty. 2019. https://www.mirror.co.uk/news/uk-news/global-ibuprofen-shortage-hits-uk-20465178. Accessed 1 April 2020." }, { "key": "363_CR3", "unstructured": "News B. Coronavirus and ibuprofen: separating fact from fiction. 2020. https://www.bbc.com/news/51929628. Accessed 1 April 2020." }, { "key": "363_CR4", "unstructured": "Today U. Fact check: does using ibuprofen when you have coronavirus make symptoms worse? 2020. https://www.usatoday.com/story/news/factcheck/2020/03/18/fact-check-coronavirus-and-ibuprofen-do-nsaids-make-coronavirus-worse/2865866001/. Accessed 1 April 2020." }, { "key": "363_CR5", "unstructured": "News N. Concerned about taking ibuprofen for coronavirus symptoms? Here's What Experts Say. 2020. https://www.npr.org/sections/health-shots/2020/03/18/818026613/advice-from-france-to-avoid-ibuprofen-for-covid-19-leaves-experts-baffled. Accessed 1 April 2020." }, { "key": "363_CR6", "unstructured": "Willsher K. Anti-inflammatories may aggravate Covid-19, France advises. 2020. https://www.theguardian.com/world/2020/mar/14/anti-inflammatory-drugs-may-aggravate-coronavirus-infection. Accessed 1 April 2020." }, { "DOI": "10.1016/S2213-2600(20)30116-8", "author": "L Fang", "doi-asserted-by": "publisher", "first-page": "e21", "issue": "4", "journal-title": "Lancet Respir Med", "key": "363_CR7", "unstructured": "Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir Med. 2020;8(4):e21.", "volume": "8", "year": "2020" }, { "key": "363_CR8", "unstructured": "Agency EM. EMA gives advice on the use of non-steroidal anti-inflammatories for COVID-19. 2020. https://www.ema.europa.eu/en/news/ema-gives-advice-use-non-steroidal-anti-inflammatories-covid-19. Accessed 3 May 2020." }, { "DOI": "10.1101/2020.04.11.20061994", "doi-asserted-by": "publisher", "key": "363_CR9", "unstructured": "Castro VM, Ross RA, McBride SM, Perlis RH. Identifying common pharmacotherapies associated with reduced COVID-19 morbidity using electronic health records. medRxiv. 2020. https://doi.org/10.1101/2020.04.11.20061994" }, { "key": "363_CR10", "unstructured": "DRUG USF. FDA advises patients on use of non-steroidal anti-inflammatory drugs (NSAIDs) for COVID-19. 2020. https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19. Accessed 3 May 2020." }, { "key": "363_CR11", "unstructured": "GOV.UK. Commission on Human Medicines advice on ibuprofen and coronavirus (COVID-19). 2020. https://www.gov.uk/government/news/commission-on-human-medicines-advice-on-ibuprofen-and-coronavirus-covid-19. Accessed 3 May 2020." }, { "DOI": "10.1128/JVI.00127-20", "doi-asserted-by": "publisher", "key": "363_CR12", "unstructured": "Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol. 2020;94(7):e00127–20. PMID: 31996437; PMCID: PMC7081895. https://doi.org/10.1128/JVI.00127-20" }, { "DOI": "10.1159/000375362", "author": "W Qiao", "doi-asserted-by": "publisher", "first-page": "97", "issue": "2", "journal-title": "Cardiology", "key": "363_CR13", "unstructured": "Qiao W, Wang C, Chen B, Zhang F, Liu Y, Lu Q, et al. Ibuprofen attenuates cardiac fibrosis in streptozotocin-induced diabetic rats. Cardiology. 2015;131(2):97–106.", "volume": "131", "year": "2015" }, { "DOI": "10.1002/pds.983", "author": "R Paulose-Ram", "doi-asserted-by": "publisher", "first-page": "257", "issue": "4", "journal-title": "Pharmacoepidemiol Drug Saf.", "key": "363_CR14", "unstructured": "Paulose-Ram R, Hirsch R, Dillon C, Gu Q. Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among US adults. Pharmacoepidemiol Drug Saf. 2005;14(4):257–66.", "volume": "14", "year": "2005" }, { "DOI": "10.1002/pds.732", "author": "GC Curhan", "doi-asserted-by": "publisher", "first-page": "687", "issue": "8", "journal-title": "Pharmacoepidemiol Drug Saf", "key": "363_CR15", "unstructured": "Curhan GC, Bullock AJ, Hankinson SE, Willett WC, Speizer FE, Stampfer MJ. Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Saf. 2002;11(8):687–93.", "volume": "11", "year": "2002" }, { "DOI": "10.1038/srep07027", "author": "P Yang", "doi-asserted-by": "publisher", "first-page": "7027", "journal-title": "Sci Rep", "key": "363_CR16", "unstructured": "Yang P, Gu H, Zhao Z, Wang W, Cao B, Lai C, et al. Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury. Sci Rep. 2014;4:7027.", "volume": "4", "year": "2014" }, { "DOI": "10.1038/nm1267", "author": "K Kuba", "doi-asserted-by": "publisher", "first-page": "875", "issue": "8", "journal-title": "Nat Med", "key": "363_CR17", "unstructured": "Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury. Nat Med. 2005;11(8):875–9.", "volume": "11", "year": "2005" }, { "DOI": "10.1186/s13054-017-1823-x", "author": "A Khan", "doi-asserted-by": "publisher", "first-page": "1", "issue": "1", "journal-title": "Crit Care", "key": "363_CR18", "unstructured": "Khan A, Benthin C, Zeno B, Albertson TE, Boyd J, Christie JD, et al. A pilot clinical trial of recombinant human angiotensin-converting enzyme 2 in acute respiratory distress syndrome. Crit Care. 2017;21(1):1–9.", "volume": "21", "year": "2017" }, { "key": "363_CR19", "unstructured": "Worl Health Organization WH. R&D Blueprint and COVID-19. 2020. https://www.who.int/teams/blueprint/covid-19. Accessed 12 June 2020." }, { "DOI": "10.1016/j.therap.2020.05.003", "doi-asserted-by": "publisher", "key": "363_CR20", "unstructured": "Micallef J, Soeiro T, Jonville-Béra AP. French Society of Pharmacology, Therapeutics (SFPT). Non-steroidal anti-inflammatory drugs, pharmacology and COVID-19 infection. Therapies. 2020;75(4):355-362. https://doi.org/10.1016/j.therap.2020.05.003" }, { "DOI": "10.1007/s11427-020-1643-8", "author": "Y Liu", "doi-asserted-by": "publisher", "first-page": "364", "issue": "3", "journal-title": "Sci China Life Sci", "key": "363_CR21", "unstructured": "Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 2020;63(3):364–74.", "volume": "63", "year": "2020" }, { "key": "363_CR22", "unstructured": "ClinicalTrials.gov. LIBERATE Trial in COVID-19 (LIBERATE). 2020. https://clinicaltrials.gov/ct2/show/NCT04334629. Accessed 12 June 2020." }, { "DOI": "10.1007/s10787-020-00745-z", "author": "L Smart", "doi-asserted-by": "publisher", "first-page": "1141", "journal-title": "Inflammopharmacol", "key": "363_CR23", "unstructured": "Smart L, Fawkes N, Goggin P, et al. A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality. Inflammopharmacol. 2020;28:1141–52. https://doi.org/10.1007/s10787-020-00745-z.", "volume": "28", "year": "2020" }, { "author": "C Amici", "first-page": "1021", "issue": "8", "journal-title": "Antiviral Therapy", "key": "363_CR24", "unstructured": "Amici C, Di Coro A, Ciucci A, Chiappa L, Castilletti C, Martella V, et al. Indomethacin has a potent antiviral activity against SARS coronavirus. Antiviral Therapy. 2006;11(8):1021.", "volume": "11", "year": "2006" }, { "DOI": "10.1128/AAC.02335-12", "author": "N Lejal", "doi-asserted-by": "publisher", "first-page": "2231", "issue": "5", "journal-title": "Antimicrob Agents Chemother", "key": "363_CR25", "unstructured": "Lejal N, Tarus B, Bouguyon E, Chenavas S, Bertho N, Delmas B, et al. Structure-based discovery of the novel antiviral properties of naproxen against the nucleoprotein of influenza A virus. Antimicrob Agents Chemother. 2013;57(5):2231–42.", "volume": "57", "year": "2013" }, { "DOI": "10.1016/j.celrep.2019.04.053", "author": "W Zheng", "doi-asserted-by": "publisher", "first-page": "1875", "issue": "6", "journal-title": "Cell Rep.", "key": "363_CR26", "unstructured": "Zheng W, Fan W, Zhang S, Jiao P, Shang Y, Cui L, et al. Naproxen exhibits broad anti-influenza virus activity in mice by impeding viral nucleoprotein nuclear export. Cell Rep. 2019;27(6):1875-855.e5.", "volume": "27", "year": "2019" }, { "DOI": "10.1136/bmj.m406", "doi-asserted-by": "crossref", "key": "363_CR27", "unstructured": "SafiDahaj F. RE: Response to the emerging novel coronavirus outbreak: British Medical Journal Publishing Group. 2020. https://www.bmj.com/content/368/bmj.m406/rapid-responses. Accessed 12 June 2020." }, { "key": "363_CR28", "unstructured": "ClinicalTrials.gov. Efficacy of addition of naproxen in the treatment of critically ill patients hospitalized for COVID-19 infection (ENACOVID). 2020. https://clinicaltrials.gov/ct2/show/NCT04325633. Accessed 12 June 2020." } ], "reference-count": 28, "references-count": 28, "relation": {}, "resource": { "primary": { "URL": "http://link.springer.com/10.1007/s40121-020-00363-w" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [ "Infectious Diseases", "Microbiology (medical)" ], "subtitle": [], "title": "Ibuprofen and NSAID Use in COVID-19 Infected Patients Is Not Associated with Worse Outcomes: A Prospective Cohort Study", "type": "journal-article", "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy", "volume": "10" }